Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Miedema

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Review of Neurotherapeutics|September 26, 2012
Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic strokeIrene Miedema, Maarten Uyttenboogaart, Gert-Jan Luijckx
JAMA|October 4, 2012
Bleeding risk with ischemic stroke therapyIrene Miedema, Gert-Jan Luijckx, Maarten Uyttenboogaart
Sleep Medicine: X|April 19, 2021
Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overviewDavid Mantle, Marcel Smits, Myrthe Boss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2012
Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysisIrene Miedema, Gert-Jan Luijckx, Jacques De Keyser, et al.
BMC Neurology|July 17, 2016
Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes?Irene Miedema, Gert-Jan Luijckx, Raf Brouns, et al.
Journal of the Neurological Sciences|May 29, 2012
Lack of association between serum uric acid levels and outcome in acute ischemic strokeIrene Miedema, Maarten Uyttenboogaart, Marcus Koch, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2011
Prior anticoagulant therapy, subtherapeutic international normalized ratio and thrombolytic therapy in acute ischemic strokeIrene Miedema, Alex Gosselt, Jacques de Keyser, et al.
Epilepsia Open|March 29, 2018
Unusual Course of Lafora DiseaseRodi Zutt, Gea Drost, Yvonne J Vos, et al.
The Lancet. Neurology|September 4, 2022
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trialSophie A van den Berg, Simone M Uniken Venema, Hendrik Reinink, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Review of Neurotherapeutics|September 26, 2012
Statin use and lipid profile in relation to safety and functional outcome after thrombolysis in ischemic strokeIrene Miedema, Maarten Uyttenboogaart, Gert-Jan Luijckx
JAMA|October 4, 2012
Bleeding risk with ischemic stroke therapyIrene Miedema, Gert-Jan Luijckx, Maarten Uyttenboogaart
Sleep Medicine: X|April 19, 2021
Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overviewDavid Mantle, Marcel Smits, Myrthe Boss, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 2, 2012
Thrombolytic therapy for ischaemic stroke in patients using warfarin: a systematic review and meta-analysisIrene Miedema, Gert-Jan Luijckx, Jacques De Keyser, et al.
BMC Neurology|July 17, 2016
Admission hyperglycemia and outcome after intravenous thrombolysis: is there a difference among the stroke-subtypes?Irene Miedema, Gert-Jan Luijckx, Raf Brouns, et al.
Journal of the Neurological Sciences|May 29, 2012
Lack of association between serum uric acid levels and outcome in acute ischemic strokeIrene Miedema, Maarten Uyttenboogaart, Marcus Koch, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2011
Prior anticoagulant therapy, subtherapeutic international normalized ratio and thrombolytic therapy in acute ischemic strokeIrene Miedema, Alex Gosselt, Jacques de Keyser, et al.
Epilepsia Open|March 29, 2018
Unusual Course of Lafora DiseaseRodi Zutt, Gea Drost, Yvonne J Vos, et al.
The Lancet. Neurology|September 4, 2022
Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trialSophie A van den Berg, Simone M Uniken Venema, Hendrik Reinink, et al.
Pageof 1